Authors
McLaurin, Eugene MD; Cavet, Megan E. PhD; Gomes, Paul J. MS; Ciolino, Joseph B. MD

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

publication date
see more

Abstract/Introduction

SIGNIFICANCE 

The α2-adrenergic receptor agonist brimonidine has been reported to induce conjunctival blanching in cataract, strabismus, laser refractive, and filtration procedures. Clinicians are often faced with red eyes with no apparent underlying pathology. Low-dose brimonidine reduced ocular redness in such subjects with efficacy maintained over 1 month and negligible rebound redness.

PURPOSE 

The aim of this study was to evaluate the safety and efficacy of brimonidine tartrate ophthalmic solution 0.025% for the treatment of ocular redness.

METHODS 

In this single-center, double-masked, phase 3 clinical trial, adult subjects with baseline redness of more than 1 unit in both eyes (0- to 4-unit scale) were randomized 2:1 to brimonidine 0.025% or vehicle. A single dose was administered in-office (day 1); thereafter subjects instilled treatment four times a day for 4 weeks, with clinic visits on days 15, 29, and 36 (7 days post-treatment). Efficacy end points included investigator-evaluated redness 5 to 240 minutes post-instillation on day 1 (primary); investigator-evaluated change from baseline 1, 360, and 480 minutes post-instillation on day 1, and 1 and 5 minutes post-instillation on days 15 and 29; total clearance of redness, and subject-assessed redness. Safety/tolerability measures included adverse events, rebound redness, and drop comfort.


Conclusion/Results

RESULTS 

Sixty subjects were randomized (n = 40 brimonidine, n = 20 vehicle). Investigator-assessed redness was lower with brimonidine versus vehicle over the 5- to 240-minute post-instillation period (mean [SE], 0.62 [0.076] vs. 1.49 [0.108]; P < .0001) and at each time point within that period (P < .0001). At 1, 360, and 480 minutes post-instillation, respectively, the mean differences (95% confidence interval) between treatments were −0.73 (−1.05 to −0.41), −0.57 (−0.84 to −0.29), and −0.39 (−0.67 to −0.10), respectively. No tachyphylaxis was evident with brimonidine on days 15 and 29, and minimal rebound redness was observed following discontinuation. Adverse events were infrequent, and brimonidine was rated as very comfortable.

CONCLUSIONS 

Brimonidine 0.025% appeared safe and effective for reduction of ocular redness, with an 8-hour duration of action, no evidence of tachyphylaxis, and negligible rebound redness.


Testimonials


  • Vision therapy is well worth the response, time and effort. Our Son had a hard time focusing and writing neatly. After vision therapy Seth could complete a task in half the time if previously took. His abilities to focus improved greatly and so did his handwriting.

    Also, he was better at listening. As a parent, we wanted learning to be fun for our Son, and vision therapy made this possible.


    Amanda T.

  • Vision Therapy is well worth the expense, time and effort. Our son had a hard time focusing handwriting neatly. After vision therapy Seth could complete a task in half the time it previously took his abilities to focus and improved greatly and so did his handwriting.

    Also, he was better at listening. As a parent you wanted learning to be fun for our son and vision therapy made this possible.


    Alexa H.

  • Vision Therapy has given or son the tools he needs to be able to scan and read the written word more effectively and efficiently.

    He love working with John and these working sessions give him the motivation to gladly work on his homework assignments.

    It amazed us to see the difference in the tracking of his eyes and along a line of it's from the beginning to the end of the treatment.

    Dr. McBryar , Kristen and John  are all marvelous and we would recommend them to anyone I only wish that we would have found them sooner!


    Charlotte M.

  • Prior to coming to the institute for vision development my son complained of daily headaches. Therapy has eliminated his headaches completely. I love knowing my son is able to learn pain-free for the rest of his life because of the work that has been done over just a few weeks in this office. He he absolutely loved coming that didn't even feel like going to a doctor or therapy. We are grateful for the relief he was able to find by coming here.

    Thank you!


    Olivia C.

  • Seems much less frustrated with life

    Reads non-stop and fast

    Spelling abilities have been hugely improved

    Seems much more confident

    Thank You!!!


    Kelly O.

Blog

group-of-small-nursery-school-children-with-teache-W2UF5RU

Vision Among Us

One of the challenges with visual impairments and visual deficits is that it's difficult to detect them just by looking […]

Read More
frustrated-millennial-businessman-having-strong-headache-tired-from-laptop-work

Vision Therapy for Neurological Conditions

Each year an estimated 1.5 million Americans sustain a traumatic brain injury (TBI). According to the Neuro Optometric Rehabilitation Association, […]

Read More
DSC_2077

Vision Therapy for Adults

Adults generally accept changes in themselves as part of aging, and think that there's nothing they can do about it. […]

Read More
see all blogs

Contact Us To Amplify Your EyeCare

Working Hours

Monday - Thursday
8:00 am - 5:15pm
friday-sunday
Closed
Location
1043 Executive Drive Suite #101 Hixson, TN 37343
Website Accessibility Policy
Safety protocols page
phone-handsetarrow-uparrow-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram